|
Volumn 29, Issue SUPPL. 2, 2008, Pages 184-186
|
Molecular basis of targeted therapy in metastatic renal cancer;Molekulare basis der zielgerichteten therapien bei metastasierenden nierenzellkarzinomen
|
Author keywords
Kinase inhibitors; Metastasis; Renal cancer; Targeted therapy; VHL
|
Indexed keywords
SORAFENIB;
SUNITINIB;
TEMSIROLIMUS;
ADVANCED CANCER;
CANCER CHEMOTHERAPY;
CONFERENCE PAPER;
GENE EXPRESSION;
HUMAN;
KIDNEY CARCINOMA;
KIDNEY METASTASIS;
MOLECULAR GENETICS;
MUTATION;
ANTINEOPLASTIC AGENTS;
BENZENESULFONATES;
CARCINOMA, RENAL CELL;
CLINICAL TRIALS, PHASE III AS TOPIC;
DRUG DELIVERY SYSTEMS;
HUMANS;
INDOLES;
KIDNEY NEOPLASMS;
PYRIDINES;
PYRROLES;
SIGNAL TRANSDUCTION;
SIROLIMUS;
VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;
|
EID: 57449105719
PISSN: 01728113
EISSN: None
Source Type: Journal
DOI: 10.1007/s00292-008-1035-x Document Type: Conference Paper |
Times cited : (2)
|
References (23)
|